Gastroenterology · Hepatobiliary Disease
The facts most likely to be tested
Primary Sclerosing Cholangitis is most strongly associated with Ulcerative Colitis, occurring in approximately 80% of patients.
The gold standard diagnostic imaging is Magnetic Resonance Cholangiopancreatography (MRCP), which reveals multifocal strictures and dilations of the bile ducts.
Cholangiography classically demonstrates a beads-on-a-string appearance due to alternating areas of fibrotic strictures and ductal dilation.
Patients typically present with progressive cholestasis, characterized by elevated alkaline phosphatase (ALP) and conjugated bilirubin levels.
The most common autoantibody associated with this condition is p-ANCA (perinuclear anti-neutrophil cytoplasmic antibody).
Chronic inflammation of the biliary tree significantly increases the long-term risk of developing cholangiocarcinoma.
Definitive management for patients with end-stage liver disease or recurrent, refractory bacterial cholangitis is liver transplantation.
Vignette unlocked
A 35-year-old male with a long-standing history of ulcerative colitis presents to the clinic with fatigue, pruritus, and jaundice. Laboratory studies reveal an elevated alkaline phosphatase of 450 U/L and a conjugated bilirubin of 3.2 mg/dL. An abdominal ultrasound is unremarkable, but subsequent MRCP demonstrates multifocal strictures and dilations of the intrahepatic and extrahepatic bile ducts. The patient's p-ANCA is positive.
What is the most likely diagnosis?
Primary Sclerosing Cholangitis
The patient's history of ulcerative colitis combined with the classic 'beads-on-a-string' appearance on MRCP and elevated cholestatic liver enzymes is pathognomonic for Primary Sclerosing Cholangitis.
Full handout
High yield triage
Etiology / Epidemiology
Strongly associated with Ulcerative Colitis (80% of cases); predominantly affects young to middle-aged men.
Clinical Manifestations
Presents with progressive jaundice, pruritus, and onion-skin fibrosis; suspect in UC patients with elevated alkaline phosphatase.
Diagnosis
MRCP is the diagnostic test of choice; shows multifocal strictures and dilation of bile ducts.
Treatment
Management is primarily liver transplantation; ursodeoxycholic acid does not improve survival.
Prognosis
High risk of cholangiocarcinoma; requires annual surveillance with MRCP/CA 19-9.
Full handout
Epidemiology & Etiology
PSC is an idiopathic, chronic inflammatory disorder of the biliary tree. It is most common in males aged 30-50. There is a massive, well-documented association with Inflammatory Bowel Disease, specifically Ulcerative Colitis.
Pertinent Anatomy
The disease involves both intrahepatic and extrahepatic bile ducts. Inflammation leads to diffuse, irregular strictures that create a characteristic beaded appearance on imaging.
Pathophysiology
Chronic inflammation leads to progressive fibrosis of the bile ducts. This results in cholestasis, biliary cirrhosis, and eventually portal hypertension. The process is immune-mediated, though the exact autoantigen remains unknown.
Clinical Manifestations
Patients often present with fatigue, pruritus, and jaundice. Ascending cholangitis is a frequent complication due to biliary stasis. Physical exam may reveal hepatosplenomegaly and signs of chronic liver disease.
Diagnosis
The MRCP (Magnetic Resonance Cholangiopancreatography) is the non-invasive gold standard. ERCP is reserved for therapeutic intervention. Labs show a cholestatic pattern with significantly elevated alkaline phosphatase.
Treatment
There is no effective medical therapy to halt disease progression. Liver transplantation is the only definitive treatment for end-stage disease. Ursodeoxycholic acid is often used for symptom relief but does not alter the disease course. Endoscopic dilation is used for dominant strictures.
Prognosis
Patients are at a significantly increased risk for cholangiocarcinoma (10-20% lifetime risk). Annual screening with MRCP and CA 19-9 is mandatory. The disease is progressive and often leads to liver failure.
Differential Diagnosis
Primary Biliary Cholangitis: affects middle-aged women, AMA positive, intrahepatic only
Secondary Sclerosing Cholangitis: history of biliary surgery or trauma
Choledocholithiasis: acute onset, usually associated with gallstones
Cholangiocarcinoma: rapid weight loss, mass effect on imaging
IgG4-related sclerosing cholangitis: elevated serum IgG4 levels